Folic Acid Utilization Ability Genetic Detection
The genetic testing for folic acid utilization can understand the body's ability to utilize folic acid from the gene level, and to realize the personalized supplementation of folic acid, thereby preventing occurrence of disease.
Y Chromosome Microdeletion Gene Detection
The spermatogenesis disorders caused by genetic factors such as chromosomal abnormalities and gene mutations account for more than 30%, of which the Y chromosome microdeletion is the second largest genetic factor leading to male infertility.
DMD (Duchenne muscular dystrophy)/ BMD (Becker muscular dystrophy) Genetic Detection
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are neuromuscular disorders that primarily affect boys due to an X-linked mutation in the DMD gene, resulting in reduced to near absence of dystrophin or expression of truncated forms of dystrophin.
17 Common Single-gene Disorders
17 common single-gene disorders panel of CapitalBiotech uses NGS combined with multi-method platform to detect common recessive genetic diseases, multiple variant types are detected at one time.
Neuromuscular Disorders
There are 1,314 genetic diseases included in this test, which can be divided into 5 categories: peripheral neuropathy, muscular dystrophy, myopathy, muscular neuropathy, systemic neuropathy.
The Disease Susceptibility Genetic Test-APOE
The test is based on biochip technology. By detecting two gene loci that determine APOE protein polymorphism, it evaluates their impact on the risk of cardiovascular and cerebrovascular diseases, and metabolic diseases.
Epilepsy-related Gene Detection
The Epilepsy-related gene testing of CapitalBiotech is based on BES4000 semi-conductor sequencing platform, using target region capture and NGS technology together to detect the genes related to epilepsy.